{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T03:56:08Z","timestamp":1720238168118},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.ijcard.2015.11.056","type":"journal-article","created":{"date-parts":[[2015,11,7]],"date-time":"2015-11-07T07:15:17Z","timestamp":1446880517000},"page":"740-741","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Use of calcium channel blockers in prostate cancer: Friends or foe?"],"prefix":"10.1016","volume":"203","author":[{"given":"Qian-Feng","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Feng","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tai","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng-Chen","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2015.11.056_bb0005","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijcard.2015.08.046","article-title":"No evidence for increased prostate cancer risk among calcium channel blockers user","volume":"201","author":"Fan","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2015.11.056_bb0010","first-page":"343","article-title":"Radioprotective effect of calcium channel blockers against late rectal bleeding in prostate cancer","volume":"119","author":"Massaccesi","year":"2014","journal-title":"Radiol. Med."},{"key":"10.1016\/j.ijcard.2015.11.056_bb0015","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1124\/jpet.111.188151","article-title":"Diltiazem enhances the apoptotic effects of proteasome inhibitors to induce prostate cancer cell death","volume":"341","author":"Kaddour-Djebbar","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ijcard.2015.11.056_bb0020","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.urolonc.2013.05.011","article-title":"Cav1.3 channnel \u03b11D protein is overezpressed and modulates androgen receptor transactivation in prostate cencers","volume":"32","author":"Chen","year":"2014","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.ijcard.2015.11.056_bb0025","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/pros.22632","article-title":"The association between calcium channel blocker use and prostate cancer outcome","volume":"73","author":"Poch","year":"2013","journal-title":"Prostate"},{"key":"10.1016\/j.ijcard.2015.11.056_bb0030","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1023\/B:CACO.0000036152.58271.5e","article-title":"Antihypertensive drug use and the risk of prostate cancer (Canada)","volume":"15","author":"Perronl","year":"2004","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ijcard.2015.11.056_bb0040","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/sj.cdd.4402162","article-title":"Ion channels in death and differentiation of prostate cancer cells","volume":"14","author":"Prevarskaya","year":"2007","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ijcard.2015.11.056_bb0045","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S0895-7061(98)00120-4","article-title":"Apoptosis in vasculature of spontaneously hypertensive rats: effect of angiotensin converting enzyme inhibitor and calcium channel antagonist","volume":"11","author":"Sharifi","year":"1998","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.ijcard.2015.11.056_bb0050","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s00125-001-0765-6","article-title":"Longacting valcium channel blocker benidipine suppresses expression of angiogenic growth factors and prevents cardiac remodeling in a type II diabetic rat model","volume":"45","author":"Jesmin","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.ijcard.2015.11.056_bb0055","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ijcard.2013.11.001","article-title":"A statement on ethical standards in publishing scientific articles in the international journal of cardiology family of journals","volume":"170","author":"Shewan","year":"2014","journal-title":"Int. J. Cardiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527315308676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527315308676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T23:26:54Z","timestamp":1537226814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527315308676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":10,"alternative-id":["S0167527315308676"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2015.11.056","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of calcium channel blockers in prostate cancer: Friends or foe?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2015.11.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}